Benzinga's Top Upgrades

Stifel Nicolaus upgraded Target

TGT

from Hold to Buy. The price target for Target Corporation is set to $76. Target's shares closed at $64.17 on Friday. Goldman Sachs upgraded BioMarin Pharmaceutical

BMRN

from Neutral to Buy. The price target for BioMarin Pharmaceutical has been raised from $78.00 to $104.00. BioMarin Pharmaceutical's shares closed at $83.91 on Friday. Analysts at Deutsche Bank upgraded Newfield Exploration Company

NFX

from Hold to Buy. The price target for Newfield Exploration has been raised from $38.00 to $42.00. Newfield Exploration shares closed at $33.57 on Friday. Analysts at Keefe Bruyette & Woods upgraded Nationstar Mortgage Holdings

NSM

from Underperform to Market Perform. The price target for Nationstar Mortgage Holdings is set to $30. Nationstar Mortgage Holdings' shares closed at $29.83 on Friday.

Market News and Data brought to you by Benzinga APIs

-

-

-

-

-

-

-

25% Off Benzinga's Most Powerful Trading Tools

-

-

-

-

-

-

-